Timothy I. Still - 14 Oct 2025 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Role: Director
Signature: /s/ Timothy I. Still
Issuer symbol: VNRX
Transactions as of: 14 Oct 2025
Net transactions value: +$25,000
Form type: 4
Filing time: 15 Oct 2025, 16:05:10 UTC
Previous filing: 10 Dec 2024
Next filing: 23 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
STILL TIMOTHY I	Director	1489 WEST WARM SPRINGS ROAD,, SUITE 110, HENDERSON	/s/ Timothy I. Still	15 Oct 2025	0001200616

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VNRX	Common Stock	Purchase	$24,519	+48,076	+3.2%	$0.5100	1,535,458	14 Oct 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VNRX	Warrant (Right to Buy)	Purchase	$481	+48,076		$0.0100^*	48,076	14 Oct 2025	Common Stock	48,076	$0.6000	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares of common stock and accompanying common stock warrants were purchased by the reporting person from the underwriter in connection with an underwritten public offering by the Issuer. The offering closed on October 14, 2025. The reported sale price reflects the price of $0.52 per share of common stock and accompanying warrant to purchase one additional share of common stock, of which $0.01 of the sale price was allocated to the warrant.

Content

The shares of common stock and accompanying common stock warrants were purchased by the reporting person from the underwriter in connection with an underwritten public offering by the Issuer. The offering closed on October 14, 2025. The reported sale price reflects the price of $0.52 per share of common stock and accompanying warrant to purchase one additional share of common stock, of which $0.01 of the sale price was allocated to the warrant.